Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic

被引：5

作者：

Wang, Li ^{[1
]}

Jiang, Man ^{[1
]}

Qu, Jialin ^{[1
]}

Zhou, Na ^{[1
]}

Zhang, Xiaochun ^{[1
]}

机构：

[1] Qingdao Univ, Affiliated Hosp, Precis Med Ctr Oncol, 16 Jiangsu Rd, Qingdao 266003, Peoples R China

来源：

INFECTIOUS AGENTS AND CANCER | 2020年 / 15卷 / 01期

关键词：

COVID-19; Lung cancer; Patient management; IMMUNE CHECKPOINT INHIBITOR; EBOLA-VIRUS; CONVALESCENT PLASMA; SPIKE PROTEIN; CORONAVIRUS; SARS; CHEMOTHERAPY; RECEPTOR; BINDING; ACE2;

D O I：

10.1186/s13027-020-00322-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The rapid growth of 2019 novel coronavirus (COVID-19) outbreak in Wuhan, China, at the early December 2019. COVID-19 spread all over the word just a few months. The outbreak of COVID-19 infection poses major threat to international health and economy. World Health Organization (WHO) announced that the new coronavirus was an international public health emergency on January 30, 2020. However, with the spread of COVID-19, the routine medical care of lung cancer patients was affected. Because lung cancer patients have low immunity after anti-tumor treatment, they should become the main targets for epidemic prevention. Lung cancer patients are increasingly concerned about the prevention of COVID-19. It is necessary to provide individualized medical treatment and management for lung cancer patients based on patients' conditions and regional epidemic patterns.

引用

页数：8

共 87 条

[1] Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance [J].

Agostini, Maria L. ;

Pruijssers, Andrea J. ;

Chappell, James D. ;

Gribble, Jennifer ;

Lu, Xiaotao ;

Andres, Erica L. ;

Bluemling, Gregory R. ;

Lockwood, Mark A. ;

Sheahan, Timothy P. ;

Sims, Amy C. ;

Natchus, Michael G. ;

Saindane, Manohar ;

Kolykhalov, Alexander A. ;

Painter, George R. ;

Baric, Ralph S. ;

Denison, Mark R. .

JOURNAL OF VIROLOGY, 2019, 93 (24)

[2]

[Anonymous], 2003, SUMM PROB SARS CAS O

[3]

[Anonymous], 2013, COAL CHEM IND, V5, P1

[4]

Ayelech M, 2019, CROSS SECTIONAL STUD

[5] Bats and Coronaviruses [J].

Banerjee, Arinjay ;

Kulcsar, Kirsten ;

Misra, Vikram ;

Frieman, Matthew ;

Mossman, Karen .

VIRUSES-BASEL, 2019, 11 (01)

[6] Ebola virus convalescent blood products: Where we are now and where we may need to go [J].

Burnouf, Thierry ;

Seghatchian, Jerard .

TRANSFUSION AND APHERESIS SCIENCE, 2014, 51 (02) :120-125

[7] Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis [J].

Bustin, SA ;

Mueller, R .

CLINICAL SCIENCE, 2005, 109 (04) :365-379

[8] Health surveillance during covid-19 pandemic [J].

Calvo, Rafael A. ;

Deterding, Sebastian ;

Ryan, Richard M. .

BMJ-BRITISH MEDICAL JOURNAL, 2020, 369

[9] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster [J].

Chan, Jasper Fuk-Woo ;

Yuan, Shuofeng ;

Kok, Kin-Hang ;

To, Kelvin Kai-Wang ;

Chu, Hin ;

Yang, Jin ;

Xing, Fanfan ;

Liu, Jieling ;

Yip, Cyril Chik-Yan ;

Poon, Rosana Wing-Shan ;

Tsoi, Hoi-Wah ;

Lo, Simon Kam-Fai ;

Chan, Kwok-Hung ;

Poon, Vincent Kwok-Man ;

Chan, Wan-Mui ;

Ip, Jonathan Daniel ;

Cai, Jian-Piao ;

Cheng, Vincent Chi-Chung ;

Chen, Honglin ;

Hui, Christopher Kim-Ming ;

Yuen, Kwok-Yung .

LANCET, 2020, 395 (10223) :514-523

[10]

Chan K. S., 2003, Hong Kong Medical Journal, V9, P399

← 1 2 3 4 5 6 7 8 9 →